Programmed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis(Figure presented.)

Scot A. Niglio; Rachel Jia; Jiayi Ji; Samuel Ruder; Vaibhav G. Patel; Alberto Martini; John P. Sfakianos; Kathryn E. Marqueen; Nikhil Waingankar; Reza Mehrazin; Peter Wiklund; William K. Oh; Madhu Mazumdar; Bart S. Ferket; Matthew D. Galsky

doi:10.1016/j.eururo.2019.05.037

Programmed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis(Figure presented.)

Scot A. Niglio, Rachel Jia, Jiayi Ji, Samuel Ruder, Vaibhav G. Patel, Alberto Martini, John P. Sfakianos, Kathryn E. Marqueen, Nikhil Waingankar, Reza Mehrazin, Peter Wiklund, William K. Oh, Madhu Mazumdar, Bart S. Ferket, Matthew D. Galsky

Research output: Contribution to journal › Review article › peer-review

40 Scopus citations

Abstract

Restricted mean survival time estimates may be used to benchmark survival outcomes and inform future trial design.Programmed death-1 and programmed death ligand-1 blockade in patients with platinum-resistant metastatic urothelial cancer yield comparable survival outcomes.

Original language	English
Pages (from-to)	782-789
Number of pages	8
Journal	European Urology
Volume	76
Issue number	6
DOIs	https://doi.org/10.1016/j.eururo.2019.05.037
State	Published - Dec 2019

Keywords

Bladder cancer
Immune checkpoint blockade
Meta-analysis
Programmed death ligand-1 blockade
Programmed death-1 blockade
Urothelial cancer

Access to Document

10.1016/j.eururo.2019.05.037

Cite this

Niglio, S. A., Jia, R., Ji, J., Ruder, S., Patel, V. G., Martini, A., Sfakianos, J. P., Marqueen, K. E., Waingankar, N., Mehrazin, R., Wiklund, P., Oh, W. K., Mazumdar, M., Ferket, B. S., & Galsky, M. D. (2019). Programmed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis(Figure presented.). European Urology, 76(6), 782-789. https://doi.org/10.1016/j.eururo.2019.05.037

@article{e27804522d104e4a8cc9a77873340055,

title = "Programmed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis(Figure presented.)",

abstract = "Restricted mean survival time estimates may be used to benchmark survival outcomes and inform future trial design.Programmed death-1 and programmed death ligand-1 blockade in patients with platinum-resistant metastatic urothelial cancer yield comparable survival outcomes.",

keywords = "Bladder cancer, Immune checkpoint blockade, Meta-analysis, Programmed death ligand-1 blockade, Programmed death-1 blockade, Urothelial cancer",

author = "Niglio, {Scot A.} and Rachel Jia and Jiayi Ji and Samuel Ruder and Patel, {Vaibhav G.} and Alberto Martini and Sfakianos, {John P.} and Marqueen, {Kathryn E.} and Nikhil Waingankar and Reza Mehrazin and Peter Wiklund and Oh, {William K.} and Madhu Mazumdar and Ferket, {Bart S.} and Galsky, {Matthew D.}",

note = "Publisher Copyright: {\textcopyright} 2019 European Association of Urology",

year = "2019",

month = dec,

doi = "10.1016/j.eururo.2019.05.037",

language = "English",

volume = "76",

pages = "782--789",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "6",

}

Niglio, SA, Jia, R, Ji, J, Ruder, S, Patel, VG, Martini, A, Sfakianos, JP, Marqueen, KE, Waingankar, N, Mehrazin, R, Wiklund, P , Oh, WK , Mazumdar, M , Ferket, BS & Galsky, MD 2019, 'Programmed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis(Figure presented.)', European Urology, vol. 76, no. 6, pp. 782-789. https://doi.org/10.1016/j.eururo.2019.05.037

TY - JOUR

T1 - Programmed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metastatic Urothelial Cancer

T2 - A Systematic Review and Meta-analysis(Figure presented.)

AU - Niglio, Scot A.

AU - Jia, Rachel

AU - Ji, Jiayi

AU - Ruder, Samuel

AU - Patel, Vaibhav G.

AU - Martini, Alberto

AU - Sfakianos, John P.

AU - Marqueen, Kathryn E.

AU - Waingankar, Nikhil

AU - Mehrazin, Reza

AU - Wiklund, Peter

AU - Oh, William K.

AU - Mazumdar, Madhu

AU - Ferket, Bart S.

AU - Galsky, Matthew D.

PY - 2019/12

Y1 - 2019/12

N2 - Restricted mean survival time estimates may be used to benchmark survival outcomes and inform future trial design.Programmed death-1 and programmed death ligand-1 blockade in patients with platinum-resistant metastatic urothelial cancer yield comparable survival outcomes.

AB - Restricted mean survival time estimates may be used to benchmark survival outcomes and inform future trial design.Programmed death-1 and programmed death ligand-1 blockade in patients with platinum-resistant metastatic urothelial cancer yield comparable survival outcomes.

KW - Bladder cancer

KW - Immune checkpoint blockade

KW - Meta-analysis

KW - Programmed death ligand-1 blockade

KW - Programmed death-1 blockade

KW - Urothelial cancer

UR - http://www.scopus.com/inward/record.url?scp=85067065721&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2019.05.037

DO - 10.1016/j.eururo.2019.05.037

M3 - Review article

C2 - 31200951

AN - SCOPUS:85067065721

SN - 0302-2838

VL - 76

SP - 782

EP - 789

JO - European Urology

JF - European Urology

IS - 6

ER -

Programmed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis(Figure presented.)

Abstract

Keywords

Access to Document

Fingerprint

Cite this